Abstract
GHRH, in addition to stimulating the release of growth hormone (GH) from the pituitary, is a trophic factor for pituitary somatotrophs. Growth hormone-releasing hormone is also expressed in the gonads, gastrointestinal tract, pancreas, thymus, and lymphocytes, as well as in tumors of the pancreas, lung, central nervous system, and breast. Since GHRH has mitogenic effects, we examined the hypothesis that GHRH is an autocrine/paracrine growth factor in neoplastic breast tissue. The effect of disrupting endogenous GHRH on cell growth and apoptosis of MDA231 cells was examined through the use of a competitive GHRH antagonist, [N-acetyl-Tyr1, D-Arg2] fragment 1–29Amide (GHRHa). Cell proliferation was determined by direct cell counting and tritiated thymidine incorporation. Apoptosis was analyzed by examination of DNA laddering and nuclear condensation. GHRHa resulted in a dose-dependent, transient, and reversible decrease in cell number, proliferation rate, and tritiated thymidine uptake. Conversely, GHRHa led to a marked and dose-dependent increase in both DNA laddering and nuclear condensation. These results indicate that disruption of endogenous GHRH action in MDA231 cells results in both decreased cellular proliferation and increased apoptosis. Taken together, the findings suggest that endogenous GHRH acts as an autocrine/paracrine factor in the regulation of growth of at least some breast cancer cell types.
Similar content being viewed by others
References
Li, H., Zeitler, P. S., Valerius, M. T., Small, K., and Potter, S. S. (1996). EMBO J. 15, 714–724.
Zeitler, P., Downs, T. R., and Frohman, L. A. (1994) Endocrine 2, 729–733.
Asa, S. L., Kovacs, K., Stefaneanu, L., Horvath, E., Billestrup, N., Gonzalez-Manchon, C., and Vale, W. (1992). Endocrinology 131, 2083–2089.
Barinaga, M., Bilezikjian, L. M., Vale, W. W., Rosenfeld, M. G., and Evans, R. M. (1985). Nature 314, 279–281.
Billestrup, N., Swanson, L. W., and Vale, W. (1986). Proc. Natl. Acad. Sci. USA 83, 6854–6857.
Billestrup, N., Mitchell, R. L., Vale, W., and Verma, I. M. (1987). Mol. Endocrinol. 1, 300–305.
Cella, S. G., Locatelli, V., Mennini, T., et al. (1990). Endocrinology 127, 1625–1634.
Struthers, R. S., Vale, W. W., Arias, C., Sawchenko, P. E., and Montminy, M. R. (1991). Nature 350, 622–624.
Gonzalez-Crespo, S. and Boronat, A. (1991). Proc. Natl. Acad. Sci. USA 88, 8749–8753.
Berry, S. A., Srivastava, C. H., Rubin, L. R., Phipps, W. R., and Pescovitz, O. H. (1992). J. Clin. Endocinrol. Metab. 75, 281–284.
Bruhn, T. O., Mason, R. T., and Vale, W. W. (1985). Endocrinology 117, 1710–1712.
Matsubara, S., Sato, M., Mizobuchi, M., Niimi, M., and Takahara, J. (1997). Endocrinology 136, 4147–4150.
Guarcello, V., Weigent, D. A., and Blalock, J. E. (1991). Cell. Immunol. 136, 291–302.
Untergasser, G., Kranewitter, W., Schwarzler, P., Madersbacher, S., Dirnhofer, S., and Berger, P. (1997). Mol. Cell. Endocrinol. 130, 53–60.
Srivastava, C. H., Monts, B. S., Rothrock, J. K., Peredo, M. J., and Pescovitz, O. H. (1995). Endocrinology 136, 1502–1508.
Srivastava, C. H., Kelley, M. R., Monts, B. S., Wilson, T. M., Breyer, P. R., and Pescovitz, O. H. (1994). Endocrine 2, 607–610.
Srivastava, C. H., Breyer, P. R., Rothrock, J. K., Peredo, M. J., and Pescovitz, O. H. (1993). Endocrinology 133, 1478–1481.
Zeitler, P. and Siriwardana, G. (2000), Endocrine 12, 257–264.
Pombo, C. M., Zalvide, J., Gaylinn, B. D., and Dieguez, C. (2000). Endocrinology 141, 2113–2119.
Frohman, L. A. and Szabo, M. (1981). Prog. Clin. Biol. Res. 74, 259–271.
Kahan, Z., Arencibia, J. M., Csernus, V. J., Groot, K., Kineman, R. D., Robinson, W. R., and Schally, A. V. (1999). J. Clin. Endocrinol. Metab. 84, 582–589.
Chopin, L. K., and Herrington, A. C. (2001). Prostate 49, 116–121.
Khorram, O., Garthwaite, M., Grosen, E., and Golos, T. (2001). Fertil. Steril. 75, 174–179.
Leung, P. C. and Steele, G. L. (1992). Endocr. Rev. 13, 476–498.
Bagnato, A., Moretti, C., Ohnishi, J., Frajese, G., and Catt, K. (1992). Endocrinology 130, 1097–1102.
Csernus, V., Schally, A. V., Kiaris, H., and Armatis, P. (1999). Proc. Natl. Acad. Sci. USA 96, 3098–3103.
Jungwirth, A., Schally, A. V., Pinski, J., Groot, K., Armatis, P., and Halmos, G. (1997). Proc. Natl. Acad. Sci. USA 94, 5810–5813.
Jungwirth, A., Schally, A. V., Pinski, J., Halmos, G., Groot, K., Armatis, P., and Vadillo-Buenfil, M. (1987). Br. J. Cancer 75, 1585–1592.
Lamharzi, N., Schally, A. V., Koppan, M., and Groot, K. (1998). Proc. Natl. Acad. Sci. USA 95, 8864–8868.
Pinski, J., Schally, A. V., Jungwirth, A., Groot, K., Halmos, G., Armatis, P., Zarandi, M., and Vadillo-Buenfil, M. (1996). Int. J. Oncol. 9, 1099–1105.
Pinski, J., Schally, A. V., Groot, K., Halmos, G., Szepeshazi, K., Zarandi, M., and Armatis, P. (1995). J. Natl. Cancer Inst. 87, 1787–1794.
Benlot, C., Levy, L., Fontanaud, P., Roche, A., Rouannet, P., and Joubert, D. (1997). J. Clin. Endocrinol. Metab. 82, 690–696.
Barinaga, M., Yamamoto, G., Rivier, C., Vale, W. W., Evans, R. M., and Rosenfeld, M. G. (1983). Nature 306, 84,85.
Gick, G. G., Zeytin, F. N., Ling, N. C., Esch, F. S., Bancroft, C., and Brazeau, P. (1984). Proc. Natl. Acad. Sci. USA 81, 1553–1555.
Clayton, R. N., Bailey, L. C., Abbot, S. D., Detta, A., and Docherty, K. (1986). J. Endocrinol. 110, 51–57.
Clark, R. G. and Robinson, I. C. A. F. (1985). Nature 314, 281–283.
Hammer, R. E., Brinster, R. L., Rosenfeld, M. G., Evans, R. M., and Mayo, K. E. (1985). Nature 315, 413–416.
Frohman, L. A., Szabo, M., Berelowitz, M., and Stachura, M. E. (1980). J. Clin. Invest. 65, 43–54.
Asa, S. L., Scheithauer, B. W., Bilbao, J. M., et al. (1984). J. Clin. Endocrinol. Metab. 58, 796–803.
Wehrenberg, W. B., Bloch, B., and Phillips, B. J. (1984). Endocrinology 115, 1218–1220.
Wehrenberg, W. B., Voltz, D. M., Cella, S. G., Müller, E. E., and Gaillard, R. C. (1992). Neuroendocrinology 56, 509–515.
Maiter, D., Underwood, L. E., Martin, J. B., and Koenig, J. I. (1991). Endocrinology 128, 1100–1106.
Jansson, J.-O., Downs, T. R., Beamer, W. G., and Frohman, L. A. (1986). Science 232, 511,512.
Lin, S.-C., Lin, C. R., Gukovsky, I., Lusis, A. J., Sawchenko, P. E., and Rosenfeld, M. G. (1993). Nature 364, 208–213.
Burton, F. H., Hasel, K. W., Bloom, F. E., and Sutcliffe, J. G. (1991). Nature 350, 74–77.
Schally, A. V. and Varga, J. L. (1999). Trends Endocrinol. Metab. 10, 383–391.
Csernus, V., Schally, A. V., and Groot, K. (1999). Peptides 20, 843–850.
Csernus, V., Schally, A. V., and Groot, K. (1999). J. Endocrinol. 163, 269–280.
Zeitler, P., Stevens P. H., and Siriwardana, G. (1998). J. Mol. Endocrinol. 21, 363–371.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeitler, P., Siriwardana, G. Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells. Endocr 18, 85–90 (2002). https://doi.org/10.1385/ENDO:18:1:85
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:18:1:85